AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and other products. It has a research and development collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Price analytics
Returns
1 day
0.0%
1 week
-0.9%
1 month
-5.5%
3 months
9.9%
6 months
26.4%
1 year
40.8%
3 years
8.2%
Risk
Volatility (1y ann.)
41.0%
Beta vs ASX 200
-0.04
Sharpe (1y)
0.94
VaR 95% (1-day)
-3.5%
Max drawdown (1y)
-17.3%
Off 1-year high
-15.9%
Technicals
RSI(14)
54
vs 50DMA
-6.0%
vs 200DMA
7.3%
Trend
Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value45.4
Trailing P/E
27
Forward P/E
51
PEG ratio
—
EV / EBITDA
23
Price / Book
55
Price / Sales
93
Growth47.7
Revenue growth (1y)
92
Revenue CAGR (3y)
89
EPS growth (1y)
0
EPS CAGR (3y)
0
Financial Health75.6
Net debt / EBITDA
60
Interest coverage (EBIT/interest)
75
Current ratio
85
Debt / Equity
84
Quality (Profitability & Cash Flow)60.5
Return on equity
68
Return on assets
79
Operating margin
56
Net margin
39
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum68.2
6-month return vs ASX 200
100
Price vs 200-day average
74
Price vs 50-day average
20
Position in 52-week range
61
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).